Evaluation of biomarkers and surrogate endpoints in chronic disease / Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease, Board on Health Care Services, Board on Health Sciences Policy, Food and Nutrition Board, Institute of Medicine ; Christine M. Micheel and John R. Ball, editors.

Format:

Book

Contributor:

Micheel, Christine.

Ball, John, 1944-

Institute of Medicine (U.S.). Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease.

Language:

English

Subjects (All):

Biochemical markers--Evaluation.

Biochemical markers.

Chronic diseases.

Physical Description:

1 online resource (335 p.)

Edition:

1st ed.

Place of Publication:

Washington, DC : National Academies Press, c2010.

Language Note:

English

Summary:

"Many people naturally assume that the claims made for foods and nutritional supplements have the same degree of scientific grounding as those for medication, but that is not always the case. The IOM recommends that the FDA adopt a consistent scientific framework for biomarker evaluation in order to achieve a rigorous and transparent process."--Publisher's description.

Contents:

""Front Matter""; ""Reviewers""; ""Preface""; ""Acknowledgments""; ""Contents""; ""Boxes, Figures, and Tables""; ""Summary""; ""1 Introduction""; ""2 Review: Evaluating and Regulating Biomarker Use""; ""3 The Biomarker Evaluation Process""; ""4 Case Studies""; ""5 Strengthening Evidence-Based Regulation""; ""Acronyms""; ""Glossary""; ""Appendix A: Table of Papers About Biomarker Qualification""; ""Appendix B: Recommendations from Related IOM Reports""; ""Appendix C: Committee Member and Consultant Biographies""; ""Appendix D: Staff Biographies""; ""Appendix E: Workshop Agenda""

""Appendix F: Speaker Biographies""

Notes:

Description based upon print version of record.

Includes bibliographical references.

ISBN:

9786612787423

9780309157278

0309157277

9781282787421

128278742X

9780309151306

0309151309

OCLC:

923281847